CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-08). The draft was written by AI, the existence of all 1 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.7.
Verdict No. 2474 · Search date 2026-08-08 · Methodology v0.7

Multifaceted podiatry package,
does it really help with Reduced fall rate in community-dwelling older adults with disabling foot pain?

30-Second Summary
C
Evidence Grade C · 54 · Safety acceptable
The result belongs to a package, not an insole alone.
No intervention-related adverse events were reported. Poorly fitted orthoses or footwear can cause pain, blisters, or instability and should be checked by a podiatry professional.
What the
research shows
The grade is C. Of three coprimary outcomes, only falling rate succeeded: 103 falls among 153 participants (0.67/person-year) versus 161 among 152 (1.06/person-year), IRR 0.64 (95% CI 0.45-0.91). Fallers were 64/153 (42%) versus 75/152 (49%), RR 0.85 (0.66-1.08), and multiple fallers were 21/153 (14%) versus 33/152 (22%), RR 0.63 (0.38-1.04); both were null.
What the
ads claim
This must not be advertised as an insole-only effect.
*

Useful facts when choosing a product

  • The package had five linked components.
  • Exercise adherence was 66%, with 52% completing at least 75% of prescribed sessions.
  • Fifty-five percent of orthosis recipients wore them most of the time.
Gap Measurement · Verdict 2474 · C 54
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Both groups received active routine podiatry. The package added heat-molded full-length dual-density orthoses with 3-mm Poron customization where needed, footwear assessment and advice, referral to medical-grade footwear plus an A$100 voucher, 30-minute foot/ankle strengthening, stretching, and range-of-motion exercise three times weekly for six months with adherence calls at weeks 1, 4, 12, and 20, and a falls booklet. Falls were recorded on monthly calendars; 296/305 returned all 12. ACTRN12608000065392 matched all three published primary outcomes.

02

Why this is classified as C (54)

Only falling rate succeeded among three coprimary outcomes, with unblinded self-recording and orthoses provided by Foot Science International, giving C with 54 points.

Counterpoint. The population had disabling foot pain, elevated fall risk, and existing podiatry use.

Rejudgment record. Cross-check applied — Only falling rate succeeded among three coprimary outcomes, with unblinded self-recording and product provision

Scoring profile behind this grade
EndpointHHard endpoint - actual events such as death
ReplicationR1Single confirmatory trial
IndependenceI1Mixed funding sources
Effect sizeE+Meets the clinically important threshold

The scoring table and the verdict agree (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Reduced fall-event rateBThe rate was significantly lower, IRR 0.64.
Reduced proportion of fallersDThe RR 0.85 interval included 1.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Parallel randomized active-control trial, 12 months296National Health and Medical Research Council of Australia and La Trobe University central large grant scheme; original role statement: “The foot orthoses in this study were provided by Foot Science International Ltd, Christchurch, New Zealand.”Fall rate, proportion of fallers, and multiple fallersFalling rate: 103 vs 161 falls, 0.67 vs 1.06/person-year, IRR 0.64 (0.45-0.91); fallers: 42% vs 49%, RR 0.85 (0.66-1.08); multiple fallers: 14% vs 22%, RR 0.63 (0.38-1.04)Pivotal trial with public research funding and separate product provision
§

Receipt — 1 References

All 1 cited sources were verified for existence at the original page (as of 2026-08-08).

Spink MJ, et al. BMJ. 2011;342:d3411. PMID: 21680622. DOI: 10.1136/bmj.d3411. ACTRN12608000065392.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-08 · Corrections: none

Cite this verdict

Multifaceted podiatry package x fewer falls Evidence Grade C card
[Chamgap] Multifaceted podiatry package x fewer falls — Evidence Grade C·54. 1 cited sources checked. Source: https://chamgap.com/en/verdicts/joint-bone/multifaceted-podiatry-package-falls/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.